TOKYO -- Fujifilm Holdings is in final talks with Takeda Pharmaceutical to acquire a unit that produces research chemicals for the drug industry.
The Japanese conglomerate is expected to pay around 200 billion yen ($1.93 billion) for Takeda's roughly 70% stake in Wako Pure Chemical Industries. A basic agreement on the acquisition is expected as soon as this month. The goal is to complete the purchase by the end of March 2017.
